JP2008528556A5 - - Google Patents

Download PDF

Info

Publication number
JP2008528556A5
JP2008528556A5 JP2007552659A JP2007552659A JP2008528556A5 JP 2008528556 A5 JP2008528556 A5 JP 2008528556A5 JP 2007552659 A JP2007552659 A JP 2007552659A JP 2007552659 A JP2007552659 A JP 2007552659A JP 2008528556 A5 JP2008528556 A5 JP 2008528556A5
Authority
JP
Japan
Prior art keywords
alkoxy
alkyl
substituted
compounds
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007552659A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008528556A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/050557 external-priority patent/WO2006082185A1/en
Publication of JP2008528556A publication Critical patent/JP2008528556A/ja
Publication of JP2008528556A5 publication Critical patent/JP2008528556A5/ja
Withdrawn legal-status Critical Current

Links

JP2007552659A 2005-02-01 2006-01-31 新規の6−ピリジルフェナントリジン Withdrawn JP2008528556A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05100690 2005-02-01
PCT/EP2006/050557 WO2006082185A1 (en) 2005-02-01 2006-01-31 Novel 6-pyridylphenanthridines

Publications (2)

Publication Number Publication Date
JP2008528556A JP2008528556A (ja) 2008-07-31
JP2008528556A5 true JP2008528556A5 (enExample) 2009-03-19

Family

ID=34938616

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007552659A Withdrawn JP2008528556A (ja) 2005-02-01 2006-01-31 新規の6−ピリジルフェナントリジン

Country Status (10)

Country Link
US (1) US20080119505A1 (enExample)
EP (1) EP1846390B1 (enExample)
JP (1) JP2008528556A (enExample)
AT (1) ATE461189T1 (enExample)
AU (1) AU2006210231A1 (enExample)
CA (1) CA2595252A1 (enExample)
DE (1) DE602006012938D1 (enExample)
EA (1) EA200701626A1 (enExample)
ES (1) ES2342728T3 (enExample)
WO (1) WO2006082185A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
MXPA06009892A (es) * 2004-03-10 2007-03-01 Altana Pharma Ag Nuevas hidroxi-6-fenilfenantridinas sustituidas con amido y su uso como inhibidores de la fosfodiesterasa tipo 4 (pde4).
WO2009109525A1 (en) * 2008-03-03 2009-09-11 Nycomed Gmbh Use of a specific pde4 inhibitor for the treatment and/or prophylaxis of non-alcoholic fatty liver disease
US8987461B2 (en) 2012-12-06 2015-03-24 Quanticel Pharmaceuticals, Inc. Histone demethylase inhibitors
CN108658778A (zh) * 2018-06-19 2018-10-16 上海华堇生物技术有限责任公司 一种3,4-二甲氧基-β-硝基苯乙烯的新制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2250569C (en) 1996-03-26 2005-05-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel phenanthridines substituted in the 6 position
PL2589599T4 (pl) 2004-03-03 2015-06-30 Takeda Gmbh Nowe hydroksy-6-heteroarylofenantrydyny i ich zastosowanie jako inhibitorów PDE4

Similar Documents

Publication Publication Date Title
JP2014507464A5 (enExample)
JP2016513660A5 (enExample)
JP2014504646A5 (enExample)
JP2018519323A5 (enExample)
NZ595553A (en) VINYL INDAZOLYL COMPOUND; (E)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethanol
JP2016525136A5 (enExample)
NZ592297A (en) 2-Aryl-5-heteroaryl pyridine and pyrimidine derivatives as pharmaceutical active agents
JP2009536197A5 (enExample)
JP2017514830A5 (enExample)
JP2013539791A5 (enExample)
NO20072371L (no) Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister
WO2008148868A8 (en) Piperidine/piperazine derivatives
JP2010513322A5 (enExample)
NZ609955A (en) Sgc stimulators
JP2013503167A5 (enExample)
JP2018524390A5 (enExample)
JP2015535277A5 (enExample)
WO2007125405A3 (en) Substituted 2-amino-fused heterocyclic compounds
JP2013514345A5 (enExample)
JP2010510999A5 (enExample)
JP2018505887A5 (enExample)
JP2010526130A5 (enExample)
JP2014506582A5 (enExample)
DE602008001725D1 (de) 1-(1-benzylpiperidin-4-yl)benzimidazol-5-carbonsäurederivate zur behandlung von diabetes mellitus
JP2012097115A5 (enExample)